1. Engineering of Ribosome-inactivating Proteins for Improving Pharmacological Properties
   Jia-Qi Lu et al, 2020, Toxins CrossRef
2. Expression profiling of anticancer genes in colorectal cancer patients and their in vitro induction by riproximin, a ribosomal inactivating plant protein
   Asim Pervaiz et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef
3. Progress in the Treatment of Retinoblastoma
   凡 杨, 2019, World Journal of Cancer Research CrossRef
4. Fordin: A novel type I ribosome inactivating protein from Vernicia fordii modulates multiple signaling cascades leading to anti-invasive and pro-apoptotic effects in cancer cells in�vitro
   Weili Lu et al, 2018, International Journal of Oncology CrossRef
5. LINC00511-dependent inhibition of IL-24 contributes to the oncogenic role of HNF4α in colorectal cancer
   Yanyan Lu et al, 2021, American Journal of Physiology-Gastrointestinal and Liver Physiology CrossRef
6. Anticancer genes (NOXA, PAR-4, TRAIL) are de-regulated in breast cancer patients and can be targeted by using a ribosomal inactivating plant protein (riproximin)
   Asim Pervaiz et al, 2023, Molecular Biology Reports CrossRef
7. Contribution of Secondary Metabolites to the Gastroprotective Effect of Aqueous Extract of Ximenia americana L. (Olacaceae) Stem Bark in Rats
   Ticiana Aragão et al, 2018, Molecules CrossRef
8. Ribosome-Directed Therapies in Cancer
   Gazmend Temaj et al, 2022, Biomedicines CrossRef
9. Integration of medicinal plants into the traditional system of medicine for the treatment of cancer in Sokoto State, Nigeria
   Ibrahim Malami et al, 2020, Heliyon CrossRef